If you have news to share, comments or suggestions about Findings, we want to hear from you. Send us your news by clicking here.
Hoxworth Receives $1.89 Million for Blood Safety Study
Published December 2004
Hoxworth Blood Center has received a five-year, $1.89 million grant for
research into the safety and availa-bility of the blood supply.
The funding, from the National Heart, Lung, and Blood Institute
(NHLBI), will support epidemiological and laboratory studies and
surveys of blood donors. Known as the Retrovirus Epidemiology Donor
Study-II (REDS-II), it replaces a highly successful program sponsored
by the NHLBI for the past 15 years.
"Addressing issues concerned with the safety and availability of both
Greater Cincinnati's and our nation's blood supply will be the
cornerstone of the REDS-II program," says principal investigator Ronald
A. Sacher, MD, director of Hoxworth and interim dean of the UC College
Besides examining blood supply and availability, REDS-II will monitor
blood-borne infectious agents, evaluate the impact of new
disease-causing bacteria and viruses, and assess the safety of changes
in laboratory and blood donor screening protocols.
Dr. Sacher will work with co-principal investigators Susan Wilkinson,
EdD, associate director and interim director of Hoxworth, and Patricia
M. Carey, MD, Hoxworth's medical director.
Founded in 1938 and now serving 25 hospitals in the Tristate area,
Hoxworth is one of six blood centers and one coordinating center
nationwide to receive REDS-II contracts.